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The fate of 185 cadaveric liver homografts preserved for four to 24 hours with 
University of Wisconsin (UW) solution was compared with that of 180 grafts 
preserved for three to 91/2 hours with conventional Euro-Collins solution. Al-
though the average preservation time of the UW-preserved livers was almost 
twice as long as that of the Euro-Collins-preserved livers, the UW-preserved 
grafts survived at a higher rate; permitted equal patient survival; and had a lower 
rate of primary nonfunction, a reduced need for retransplantation, and a lower 
rate of hepatic artery thrombosis. There was no correlation between the time of 
preservation of UW-preserved grafts up to 24 hours and liver function abnormal-
ities in the first postoperative week. In contrast, livers preserved with Euro-
Collins solution for more than five hours had significantly increased perturba-
tions of hepatic function tests. The potential revolutionary effect of the UW 
solution on liver transplantation is described herein. 
IN SEPTEMBER 1987, Jamieson and 
Kalayoglu and their associates!'2 at the 
University of Wisconsin (UW) reported 
that cold ischemia of canine and human 
liver homografts could be extended 
safely to one day with an infusate de-
scribed by Wahlberg et al3 in experi-
ments on pancreas preservation. The 
superior qualities of their UW solution 
were confirmed in our laboratories with 
liver replacement experiments in dogs 
(S. 'lbdo, L. Podesta, Y. Ueda, et al. 
unpublished data, Pittsburgh, Dec 15, 
1988) and rats and with an isolated per-
fusion model in rats.' 
(JAMA 1989:261:711-714) 
ing the immediately preceding five-
month period. 
METHODS' 
ReCipient Case Material 
There were 164 patients who re-
ceived 185 UW-preserved livers be-
tween Oct 22, 1987, and March 21, 1988 
(Table 1), 21 (12.2%) requiring retrans-
plantation during the observation peri-
od of three to eight months. Of the 164 
patients, 151 were undergoing primary 
transplantation. The other 13 had re-
placement of a graft transplanted in the 
pre-UW era months to years earlier. 
The 152 retrospective control pa-
tients received 180 Euro-Collins-pre-
served livers between May 22, 1987, 
and Oct 21, 1987; ofthese, 28 (18%) re-
quired retransplantation. Of these re-
cipients (Table 1), 144 were undergoing 
primary transplantation while eight had 
replacement of a liver that had been 
transplanted before the study period. 
The recipients in the Euro-Collins 
group had fewer males (Table 1) than 
the UW group. 
Donor Case Material 
The donor populations in the UW and 
Euro-Collins groups (Table 2) were not 
different in age, time of hospitalization, 
cause of death, liver function, cardio-
vascular and pulmonary status, or inci-
dence of other organ removal. 
Procurement Techniques 
The techniques for multiple organ re-
moval were those originally described' 
or were modified with a rapid flush 
method for unstable donors. 7 The rapid 
method was used more commonly 
(P<.05) in the Euro-Collins group (Ta-
Herein, we report our experience 
with the first 185 human livers pre-
served with UW solution, with a mini-
mum follow-up of three months after 
transplantation. The results were com-
pared with those using 180 consecutive 
Wafts that had been infused and pre-
~erved with Euro-Collins solution' dur-
Table 1.-Comparison Between Recipients of UW vs Euro-Collins Preserved Grafts 
From the Department of Surgery, University Health 
Center of PittSburgh. University of Plnsburgh (Drs Todo 
Nery Yanaga, Podesta. Gordon, and Starzl). and the 
Veterans Administration Medical Center, Pittsburgh (Dr 
Starll) 
Reo"nt reauests 10 Department of Surgery, 3601 Filth 
Ave. Fal. Clmlc, PittSburgh, PA 15213 (Dr Starzll 
RecIpIent Data 
No. of grafts 
1st 
2nd 
3rd 
4th 
No. of patients 
Age, Y 
>18,% 
<18,% 
Sex, % 
M 
F 
Euro-Colllna 
UWGroup Group 
185 180 
151 144 
27 31 
7 4 
1 
164 152 
36.5:1:20.6 33.6:1:20.9 
78.1 71.8 
21.9 28.2 
58.5 43.S 
41.5 56.5 
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ble 2), but in previous studies. it had 
been shown that the choice of technique 
did not influence the outcome.' The he-
patic grafts were procured 95.3% of the 
time in collaboration with host renal 
teams and with heart teams from spe-
cialty centers. Some of these groups in-
sisted on abdominal aortic infusion with 
lactated Ringer's solution from the out-
set, others used different variations of 
Collins' solution, and still others had 
their own mixtures. All of the livers 
preserved before UW solution became 
available had a final back table flush 
with Euro-Collins solution through a 
portal vein cannula. 
For the UW-preserved livers, the 
procedure was the same except that on 
the back table, the portal vein was 
flushed with UW solution using 1.5 L if 
the donor weighed more than 60 kg, 1 L 
for livers from smaller donors, and 250 
to 500 mL for pediatric cases. About one 
tenth of the volume of portal vein infu-
sate was given into the hepatic artery. 
ReCipient Operations and Care 
The recipient techniques' were the 
same in the control and test cases. Just 
before revascularizing the new liver, 
the organ was reperfused with 300 to 
500 mT... of lactated Ringer's solution in 
the Euro-Collins cases to remove air 
and excess potassium, and with plas-
manate in the UW cases. Postoperative 
immunosuppression was with cyclo-
sporine and low-dose steroids,'o with 
supplementary monoclonal antilympho-
cyte (OKT3)" and/or azathioprine as 
indicated. 
End Points Compared 
Comparisons between the Euro-
Collins and UW groups included the 
cold ischemia periods, liver function 
tests, recipient survival, major com-
plications, incidence of primary non-
function of the grafts, frequency of he-
patic artery thrombosis, and need for 
retransplantation. 
Statistical Analysis 
Values were expressed as mean 
::!: SD. Comparisons were with Stu-
dent's t test, X' test, and linear regres-
sion analysis. Actuarial patient survival 
was calculated by the method of Kaplan-
Meier, and the statistical comparisons 
of patient and graft survival were made 
by the Mantel-Cox method. 
RESULTS 
Cold Ischemia Time 
All of the Euro-Collins-preserved liv-
ers were revascularized after three to 
9112 hours, whereas 81 (44%) of the UW-
preserved livers were preserved for 
longer than 9112 hours (Fig 1). with a 
712 JAMA. February 3. 1989-VoI261. No.5 
Table 2.-Comparison of Donors of UW vs Euro-Collins Preserved Grafts 
Euro-Colllna 
Donor Data UWGroup Group 
No. 01 dOnors 185 180 
Age,y 19.8:: 12.2 17.1 + 10.5 NS 
>18,% 78.1 71.8 
<18.% 21.9 28.2 
Method of procurement. % 
Rapid technique 56.6 73.4 <.05 
Regular technique 38.9 25.5 <.05 
Modified technique 4.4 1.1 NS 
·NS indicates not significant. 
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Fig 1. -Duration of cold ischemia time and number of cases in UW (open bars) and Euro-Collins (solid bars) 
groups. 
maximum of 24 hours. The mean cold 
ischemia time was 5.9::!: 1.4 (SD) hours 
for the Euro-Collins-preserved livers 
and 10.1::!:5.0 (SD) hours for the UW-
preserved livers (P<.OO1). 
Graft Function 
On the basis of previously published 
gross anatomic criteria and color, '.12 the 
UW-preserved livers were grossly su-
perior. They reperfused immediately 
with institution of portal inflow and 
almost always made bile. The clinical 
impression was that cardiovascular 
instability and coagulopathies were 
uncommon compared with the retro-
spective experience with Euro-Collins-
preserved livers. 
Although the UW livers were pre-
served longer, the maximum increases 
in serum aspartate aminotransferase 
and serum alanine aminotransferase in 
the first week were no greater than with 
the Euro-Collins-preserved livers (Fig 
2). The same was true for maximum 
prothrombin time in the first week (Fig 
3). Serum bilirubin values during the 
first four hours were almost identical 
with values of UW-preserved and Euro-
Collins-preserved livers. 
In the UW group, the time of preser-
vation had no demonstrable adverse 
effects up to 24 hours (Figs 2 and 3). In 
contrast, grafts preserved for more 
than five hours with Euro-Collins 
solution had significant increases in se-
rum aspartate aminotransferase and se-
rum alanine aminotransferase levels 
(P<.05), as well as greater prolongation 
of prothrombin time. 
Patient Survival 
After primary transplantation, the 
patient survival curves were nearly 
identical with the UW vs Euro-Collins 
groups, with actual survival at three 
months of 83% and 81%, respectively, 
and an actuarial six-month survival of 
81 % and 77%. respectively (Fig 4). 
The patients who had retransplanta-
Preservation of Liver Grafts - Todo et al 
Euro-Colhns Solution Preservation Euro-Collins SolutIon Preservation 
12000 60 
~ 
::> 
Oi 10000 
> 
'" 
50 ' 
lID 
...J 
., 
:(l 8000 
.$ 
V> 
c; 
co g 6000 
c; 
E 
..: 
., 4000 c; 
c 
co 
« 
oj 
40 E c:BO >= 
co ~ 
:0 a~ 
E 30 ~Sic 0 .c 15 0: 20 -' 0 El 0 
2000 10 
0 5 10 IS 20 25 o 5 10 15 20 25 
Cold Ischemic Time. h Cold Ischemic Tillie. h 
UW Solution Preservation 
UW Solution Preservation 
60 
12000 
~ 50 
::> 10000 6. 
l! (/) CD 40 
...J oi 6. CD 8000 E 6. (/) 6. i >= 6. 6. 6. c :0 30 6.6.&s, 6. 6. 6. c; 6000 E ~ e 
'0 
, ~ 10 10", M c s::. 'E 66 £ 20 ~SK ~~~~jSKSK ~ ..: 4000 
CD 6 c ~ tA 'c 
.. 10 
« 2000 6 
0 5 10 15 20 0 5 
10 15 20 25 
Cold Ischemic Time. h Cold Ischemic Time. h 
Fig 2. - Highest serum alanine aminotransferase values in first postoperative 
week after transplantation of livers preserved with UW (bottom) and Euro-Collins 
(top) solutions for variable periods of time. 
Fig 3.-Highest prothrombin time values in first postoperative week alter trans-
plantation of livers preserved with UW (bottom) and Euro-Collins (top) solutions 
for variable periods of time. 
tions with UW-preserved livers had a 
slightly better survival for three 
months than the recipients whose re-
transplant grafts were preserved with 
Euro-Collins solution. 
Causes of Patient Death 
Sepsis from viral, bacterial, and fun-
gal infection was the leading cause of 
death in both study groups. Primary 
graft nonfunction was responsible for 
six patient deaths in the Euro-Collins 
group compared with one in the UW 
group. 
Graft Survival 
Graft survival in 151 primary trans-
plant recipients in the UW group and 
JAMA. Feoruary 3. 1989-Vol 261. NO.5 
144 primary recipients in the Euro-Col-
lins group are shown in Fig 4. The actual 
graft survival at three months was 76% 
using UW-preserved livers vs 68% us-
ing Euro-Collins-preserved livers and 
actuarial six-month survival was 73% vs 
65%, respectively (P<.09). 
Causes of Retransplantatlon 
There were 17 retransplantations 
(11.3%) among the 151 patients who re-
ceived primary liver transplantation in 
the UW group, while in the Euro-Col-
lins group there were 29 retransplanta-
tions (20%) (Table 3). The number of 
hepatic artery thromboses was reduced 
significantly in the UW group (P<.05), 
as well as the incidence of primary graft 
Fig 4.-Patient and graft survival in UW and Euro-
Collins groups. 
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Table 3. -Causes of Retransplanlallon After Primary Grafting 
Euro-Collins 
Patient Informlltlon UWGroup Group P* 
No. of patients 151 144 
No. ot retransplants 
Hepatic artery thrombosIs 
17 (11.3%1 
7 
29 (20%1 <.1 
18 <..05 
Primary nonfunction 3 
Rejection 
Other causes of retransplantation 6 
*NS indicates not significant. 
nonfunction and rejection. The three 
primarily nonfunctioning grafts in the 
UW group (Table 3) had cold ischemia 
times of four hours and 41 minutes, five 
hours and 30 minutes, and 22 hours and 
58 minutes. Thus, there was no relation-
ship in the UW cases that required re-
transplantation between the length of 
cold ischemia times and the occurrence 
of primary graft nonfunction. 
Duration of Hospital Stay 
The mean duration of hospital stay of 
patients in the UW group was 
37.7:t 20.8 (Sm days, and that of all 
patients in the Euro-Collins group was 
40.9:t23.9 (SD) days. The mean length 
of stay in the intensive care unit was 
8.7:t 10.6 days in the UW group and 
8.8:t 14.5 (SD) days in the Euro-Collins 
group (P value, not significant). 
COMMENT 
The first step in the development of 
liver graft presenration was core cool-
ing by infusion of chilled lactated Ring-
er's solution into the portal vein. '3 To-
day. core cooling is the first step in the 
preservation of all whole-organ grafts, 
and this is most often done in situ by 
some variant of the technique described 
by Marchioro et al" for the continuous 
hypothermic perfusion of cadaveric liv-
ers and kidneys long before the accep-
tance of brain death conditions. Acker-
man and Snell'S and Merkel et al'6 
popularized in situ cooling of cadaveric 
kidneys with cold electrolyte solutions 
infused into the distal aorta. An exten-
sion of this technique has allowed re-
moval of all thoracic and abdominal or-
gans, including the liver, without 
jeopardizing any of the individual 
organs: 
Extension of the safe period of the 
liver beyond that provided by initial 
cooling has followed one of two proto-
type strategies. One approach was to 
provide a limited and continuous circu-
lation ex vivo. This was first done suc-
cessfully with a perfusate that was 
primed with blood and oxygenated 
within a hyperbaric oxygen chamber. i7 
The alternative strategy for the preser-
vation of kidnevs, livers. and other or-
gans has been" called the siush tech-
5 NS 
4 NS 
2 NS 
niquc. ",;th the instillation of special 
solutions"" and subsequent refrigera-
tion. The introduction of the UW solu-
tion!.' has been the first major develop-
ment in liver preservation since the 
description of the slush techniques by 
Benichou et al' and Wall et al. .. 
The remarkable effectiveness of the 
UW solution has revolutionized liver 
transplantation at almost every level. 
The enhanced margin of safety has per-
mitted more effective use of organs that 
can be stored safely while waiting for 
operating room facilities or personnel to 
become available. It has allowed pro-
curement of grafts from cities once con-
sidered too distant, from as far as across 
the Atlantic Ocean. It has changed the 
way in which the recipient operation is 
approached. In the past, the donor and 
the recipient operations were closely co-
ordinated to shorten the ischemic inter-
val to a minimum. Now, the graft usual-
ly is brought back to Pittsburgh and 
submitted to close scrutiny before the 
recipient is taken to the operating room. 
If desirable, there is ample time for de-
tailed histopathologic studies of graft 
biopsy specimens. Finally, the greatly 
increased margin of safe time can be 
invested in the performance of a more 
perfect recipient hepatectomy, better 
hemostasis before the graft is sewn in, 
and even leisurely removal of a part of 
the homograft if a size discrepancy ex-
ists between the graft and the hepatic 
fossa in which it is to be placed. 
It is ironic that the advantages of the 
UW solution are so obvious while the 
explanations for its efficacy are so ob-
scure. In experiments on pancreas 
transplantation, Wahlberg et al' noted 
that the weight gain commonly seen in 
organs preserved by past slush tech-
niques was avoided with their solution. 
The same observations have been made 
with livers (S. Todo, L. Podesta, Y. 
U eda, et ai, unpublished data. Pitts-
burgh, Dec 15, 1988). Minimizing "wa-
ter logging" of the endothelium of the 
microvasculature could explain the sig-
nificant reduction of hepatic artery 
thrombosis with the use of the UW flu-
id. Whatever the rationale may be for 
the effectiveness of the UW solution. lY 
inhibition of cell swelling during cold 
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storage would appear to be particularly 
important. 
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